Google Übersetzer
Modus Therapeutics Holding Ab
About
0.44SEK+0.00 +0.00%
Closed • Updated at 14:02 GMT+00:00Market Cap$5.72M
Volume689.3K
Beta5.36
RSI53.23
Modus Therapeutics Holding Ab — investor relations, events, news, and company updates on 6ix.
Latest News
Nov 14 2025
Interim Report - January-September 2025
Nov 4 2025
Karolinska Development's portfolio company Modus Therapeutics receives approval for second part of phase 2 study in chronic kidney disease with anemia
Sep 18 2025
Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer
Aug 28 2025
Karolinska Development's portfolio company Modus Therapeutics raises SEK 28.3 million in oversubscribed unit issue
Jul 14 2025
Karolinska Development's portfolio company Modus Therapeutics completes enrollment in part 1 of its phase 2a study with sevuparin
Recent Videos
Modus Therapeutics 2026-03-11 | VD John Öhd presenterar med Q&A
Mar 13, 2026
Intervju med Modus Therapeutics VD John Öhd
Mar 06, 2026
Modus Therapeutics - Rapportkommentar Q4 2025
Mar 02, 2026
Modus Therapeutics 2025-12-10 | VD John Öhd pesenterar med Q&A
Dec 11, 2025
Community Chat
Ask AI
Try asking